Differential in vitro effects of targeted therapeutics in primary human liver cancer: importance for combined liver cancer

The incidence of primary liver tumors, hepatocellular carcinoma (HCC), intrahepatic cholangiocellular carcinoma (ICC), and combined HCC/ICC (cHCC/CC) is increasing. For ICC, targeted therapy exists only for a small subpopulation of patients, while for HCC, Sorafenib and Lenvatinib are in use. Diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Ihtzaz Ahmed, Rajput, Mansi, Werner, Rieke, Fey, Dorothea, Salehzadeh, Niloofar, von Arnim, Christine A. F., Wilting, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675209/
https://www.ncbi.nlm.nih.gov/pubmed/36402986
http://dx.doi.org/10.1186/s12885-022-10247-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675209/
https://www.ncbi.nlm.nih.gov/pubmed/36402986
http://dx.doi.org/10.1186/s12885-022-10247-6

Ejemplares similares